Selective use of radioactive iodine (RAI) in thyroid cancer: no longer “one size fits all”
Abstract A remarkable, evidence-based trend toward de-escalation has reformed the practice of radioactive iodine (RAI) administration for thyroid cancer patients. Updated guidelines have supported both decreased RAI doses for select populations, as well as expanded definitions of low-risk and interm...
Saved in:
| Published in | European journal of surgical oncology Vol. 44; no. 3; pp. 348 - 356 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.03.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Abstract A remarkable, evidence-based trend toward de-escalation has reformed the practice of radioactive iodine (RAI) administration for thyroid cancer patients. Updated guidelines have supported both decreased RAI doses for select populations, as well as expanded definitions of low-risk and intermediate-risk patients that may not require RAI. Correspondingly, there is now increased flexibility for hemithyroidectomy without need for RAI, and relaxed TSH suppression targets for low-risk thyroidectomy patients. Clinical judgment remains indispensable where multiple risk factors co-exist that individually are not indications for RAI. This is especially salient in intermediate-risk patients with a less than excellent response to therapy, determined through thyroglobulin and ultrasound surveillance. Such judgement, however, may lead to patterns of inappropriate RAI practices or overuse with little benefit to the patient and unnecessary harm. A multidisciplinary, risk-adapted approach is ever more important and obliges the surgeon to understand the likelihood that their patients will receive RAI. The risks and benefits of RAI, its evolved role in contemporary guidelines, and current patterns of use among endocrinologists are reviewed, as well as the practical implications for thyroid surgeons. |
|---|---|
| AbstractList | Abstract A remarkable, evidence-based trend toward de-escalation has reformed the practice of radioactive iodine (RAI) administration for thyroid cancer patients. Updated guidelines have supported both decreased RAI doses for select populations, as well as expanded definitions of low-risk and intermediate-risk patients that may not require RAI. Correspondingly, there is now increased flexibility for hemithyroidectomy without need for RAI, and relaxed TSH suppression targets for low-risk thyroidectomy patients. Clinical judgment remains indispensable where multiple risk factors co-exist that individually are not indications for RAI. This is especially salient in intermediate-risk patients with a less than excellent response to therapy, determined through thyroglobulin and ultrasound surveillance. Such judgement, however, may lead to patterns of inappropriate RAI practices or overuse with little benefit to the patient and unnecessary harm. A multidisciplinary, risk-adapted approach is ever more important and obliges the surgeon to understand the likelihood that their patients will receive RAI. The risks and benefits of RAI, its evolved role in contemporary guidelines, and current patterns of use among endocrinologists are reviewed, as well as the practical implications for thyroid surgeons. A remarkable, evidence-based trend toward de-escalation has reformed the practice of radioactive iodine (RAI) administration for thyroid cancer patients. Updated guidelines have supported both decreased RAI doses for select populations, as well as expanded definitions of low-risk and intermediate-risk patients that may not require RAI. Correspondingly, there is now increased flexibility for hemithyroidectomy without need for RAI, and relaxed TSH suppression targets for low-risk thyroidectomy patients. Clinical judgment remains indispensable where multiple risk factors co-exist that individually are not indications for RAI. This is especially salient in intermediate-risk patients with a less than excellent response to therapy, determined through thyroglobulin and ultrasound surveillance. Such judgment, however, may lead to patterns of inappropriate RAI practices or overuse with little benefit to the patient and unnecessary harm. A multidisciplinary, risk-adapted approach is ever more important and obliges the surgeon to understand the likelihood that their patients will receive RAI. The risks and benefits of RAI, its evolved role in contemporary guidelines, and current patterns of use among endocrinologists are reviewed, as well as the practical implications for thyroid surgeons. |
| Author | Marti, Jennifer L., MD Ho, Allen S., MD Morris, Luc G.T., MD, MSc |
| Author_xml | – sequence: 1 fullname: Marti, Jennifer L., MD – sequence: 2 fullname: Morris, Luc G.T., MD, MSc – sequence: 3 fullname: Ho, Allen S., MD |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28545679$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kc9qFTEUxoNU7G31BVxIlnUxY_7NZEZEKKVqoSBY3RpykzOaMTdpk5nC7aoPoi_XJzHDbV104dkcOHzfxzm_c4D2QgyA0EtKakpo-2asYcyxZoTKmoiaEPYErWjDWcVoI_fQikjRVbLv-D46yHkkhPRc9s_QPusa0bSyX6HvF-DBTO4a8JwBxwEnbV3Uu5GL1gXAR1-Oz15jF_D0c5uis9joYCC9xSFiH8MPSPju9ndZDmd3A3hwU8ba-7vbP8_R00H7DC_u-yH69uH068mn6vzzx7OT4_PKCEqnSjJh9CB520tOm7Xm676UaCQxwjDbD6IV674TkrGm6SwIRnhnrB5awzqqOT9ER7vcyxSvZsiT2rhswHsdIM5Z0Z5wKkkjFinbSU2KOScY1GVyG522ihK1cFWjWriqhasiQhWuxfTqPn9eb8D-szyALIJ3OwGUK68dJJWNg0LJulT4Khvd__PfP7Ib74Iz2v-CLeQxzikUfoqqzBRRF8tnl8dSyYkoxf8CSsigDQ |
| CitedBy_id | crossref_primary_10_1155_2022_4348396 crossref_primary_10_3803_EnM_2020_747 crossref_primary_10_1016_j_radphyschem_2023_110897 crossref_primary_10_3389_fendo_2019_00737 crossref_primary_10_1016_j_heliyon_2021_e06624 crossref_primary_10_1210_clinem_dgac448 crossref_primary_10_20945_2359_3997000000461 crossref_primary_10_1089_thy_2019_0060 crossref_primary_10_1016_j_mayocp_2021_02_009 crossref_primary_10_1111_cen_14804 crossref_primary_10_1007_s13139_022_00756_4 crossref_primary_10_3389_fonc_2023_1185650 crossref_primary_10_3389_fendo_2023_1158826 crossref_primary_10_1016_j_ando_2018_09_006 crossref_primary_10_3390_cancers13020317 crossref_primary_10_1111_ans_15522 crossref_primary_10_1007_s12020_018_1724_z crossref_primary_10_1093_ageing_afz089 crossref_primary_10_1016_j_seppur_2021_118436 crossref_primary_10_1089_ct_2022_34_450_452 crossref_primary_10_1089_thy_2019_0274 crossref_primary_10_1016_j_ejso_2018_08_025 crossref_primary_10_1002_jso_26858 crossref_primary_10_1007_s12149_019_01432_y crossref_primary_10_1007_s13304_020_00773_y crossref_primary_10_1016_j_ejso_2019_01_021 |
| Cites_doi | 10.1089/thy.1999.9.435 10.1002/(SICI)1097-0142(20000315)88:6<1470::AID-CNCR27>3.0.CO;2-W 10.1590/S0004-27302009000900014 10.1089/thy.2008.0419 10.1089/thy.2012.0043 10.1089/thy.2012.0567 10.1089/thy.2014.0098 10.1210/jc.2010-2695 10.1111/j.1365-2265.2011.04002.x 10.1089/thy.2015.0112 10.1097/SLA.0b013e31826c8915 10.1371/journal.pone.0001885 10.1089/thy.2008.0243 10.1016/j.surg.2011.08.016 10.1016/S2213-8587(16)30112-7 10.1038/sj.bjc.6601319 10.1210/jc.2007-0225 10.1210/jc.2012-3630 10.1530/EJE-07-0399 10.1210/jc.2012-1533 10.1210/jc.2012-3160 10.1089/thy.2009.0455 10.1007/s00268-013-2224-1 10.1056/NEJMoa1108586 10.1089/thy.2006.16.1229 10.1007/s10434-004-1165-1 10.1097/SLA.0b013e31814697d9 10.1056/NEJMoa1109589 10.1016/S0001-2998(79)80023-9 10.1530/eje.1.02158 10.1002/cncr.27721 10.1089/thy.2015.0020 10.1210/jc.2010-2708 10.1210/jc.2008-1931 10.1002/cncr.26070 10.3322/caac.21388 10.1016/j.surg.2011.09.007 10.1007/s00259-004-1460-x 10.1016/j.ctrv.2015.09.001 10.1016/j.oraloncology.2013.03.444 10.1089/thy.1997.7.163 10.1210/jc.2011-1379 10.1097/01.rlu.0000162602.48653.54 10.1210/jc.2012-3355 10.1016/j.surg.2010.09.019 10.1210/jc.2012-3401 10.1245/s10434-012-2745-0 10.1002/cncr.30360 10.1097/SLA.0000000000000925 10.1016/j.surg.2010.09.032 |
| ContentType | Journal Article |
| Copyright | Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology Copyright © 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved. |
| Copyright_xml | – notice: Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology – notice: 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology – notice: Copyright © 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.ejso.2017.04.002 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-2157 |
| EndPage | 356 |
| ExternalDocumentID | 10_1016_j_ejso_2017_04_002 28545679 S0748798317304444 1_s2_0_S0748798317304444 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABBQC ABFNM ABMAC ABMZM ABXDB ACDAQ ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N9A O-L O9- OAUVE OK- OW- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UDS UHS UV1 X7M Z5R ZGI ZXP ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c411t-724caf73697315ba3b99994570c4c2d9f464b984722558de42038cdaf6c281a33 |
| IEDL.DBID | AIKHN |
| ISSN | 0748-7983 |
| IngestDate | Fri Oct 25 02:22:22 EDT 2024 Thu Sep 26 17:11:21 EDT 2024 Sat Sep 28 08:46:29 EDT 2024 Fri Feb 23 02:24:45 EST 2024 Tue Oct 15 22:56:38 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | radioactive iodine de-escalation ATA Guidelines thyroidectomy thyroid cancer De-escalation Thyroid cancer Radioactive iodine Thyroidectomy |
| Language | English |
| License | Copyright © 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c411t-724caf73697315ba3b99994570c4c2d9f464b984722558de42038cdaf6c281a33 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| PMID | 28545679 |
| PQID | 1903170543 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_1903170543 crossref_primary_10_1016_j_ejso_2017_04_002 pubmed_primary_28545679 elsevier_sciencedirect_doi_10_1016_j_ejso_2017_04_002 elsevier_clinicalkeyesjournals_1_s2_0_S0748798317304444 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-03-01 |
| PublicationDateYYYYMMDD | 2018-03-01 |
| PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | European journal of surgical oncology |
| PublicationTitleAlternate | Eur J Surg Oncol |
| PublicationYear | 2018 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Sacks, Fung, Chang, Waxman, Braunstein (bib12) 2010; 20 Schuessler, Banerjee, Yang, Stewart, Doherty, Haymart (bib48) 2013; 20 Durante, Montesano, Torlontano (bib41) 2013; 98 American Joint Commission on Cancer (bib55) 2017 Ilgan, Karacalioglu, Pabuscu (bib14) 2004; 31 Haugen, Alexander, Bible (bib9) 2016; 26 Haugen (bib26) 2017 Feb 1; 123 Mazzaferri (bib21) 2007; 13 Farahati, Demidchik, Biko, Reiners (bib5) 2000; 88 Avram, Fig, Frey, Gross, Wong (bib7) 2013; 98 Tuttle, Sabra (bib23) 2013; 49 Haymart, Banerjee, Yang (bib49) 2013; 98 Schlumberger, Catargi, Borget (bib25) 2012; 366 Brassard, Borget, Edet-Sanson (bib35) 2011; 96 Nixon, Ganly, Patel (bib44) 2012; 151 Takamura, Orita, Saenko, Yamashita, Nagataki, Demidchik (bib6) 2016; 4 Durante, Filetti (bib39) 2011; 96 Haymart, Banerjee, Yang (bib50) 2013; 258 Baek, Jung, Kang (bib32) 2010; 20 Phan, Jager, van der Wal (bib38) 2008; 158 Amin, Greene, Edge (bib15) 2017; 67 Pilli, Brianzoni, Capoccetti (bib4) 2007; 92 Bilimoria, Bentrem, Ko (bib42) 2007; 246 Haymart, Banerjee, Yang, Stewart, Koenig, Griggs (bib47) 2013; 119 Alexander, Bader, Schaefer, Finke, Kirsch (bib17) 1998; 39 Hay (bib22) 2007; 13 Nascimento, Borget, Al Ghuzlan (bib37) 2011; 18 Rubino, de Vathaire, Dottorini (bib18) 2003; 89 Tufano, Clayman, Heller (bib10) 2015; 25 Hod, Hagag, Baumer, Sandbank, Horne (bib13) 2005; 30 Hughes, White, Miller, Gauger, Burney, Doherty (bib53) 2010; 148 Camargo, Corigliano, Friguglietti (bib28) 2009; 53 Randolph, Duh, Heller (bib29) 2012; 22 Maenpaa, Heikkonen, Vaalavirta, Tenhunen, Joensuu (bib3) 2008; 3 Beierwaltes (bib1) 1979; 9 Nixon, Ganly, Patel (bib30) 2011; 150 Bonnet, Hartl, Leboulleux (bib54) 2009; 94 Webb, Howard, Stojadinovic (bib33) 2012; 97 Adam, Pura, Gu (bib43) 2014; 260 Haigh, Urbach, Rotstein (bib46) 2005; 12 Pacini, Schlumberger, Dralle (bib27) 2006; 154 Matsuzu, Sugino, Masudo (bib45) 2014; 38 Malandrino, Latina, Marescalco (bib34) 2011; 96 Spencer, LoPresti, Fatemi, Nicoloff (bib36) 1999; 9 Radowsky, Howard, Burch, Stojadinovic (bib31) 2014; 24 Mallick, Harmer, Yap (bib24) 2012; 366 Zarebczan, McDonald, Rajamanickam, Leverson, Chen, Sippel (bib52) 2010; 148 Marti, Davies, Haymart, Roman, Tuttle, Morris (bib20) 2015; 25 Vaisman, Shaha, Fish, Michael Tuttle (bib40) 2011; 75 Jonklaas, Sarlis, Litofsky (bib11) 2006; 16 Iyer, Morris, Tuttle, Shaha, Ganly (bib19) 2011; 117 Haymart, Muenz, Stewart, Griggs, Banerjee (bib51) 2013; 98 Sawin, Becker (bib2) 1997; 7 Van Nostrand, Aiken, Atkins (bib8) 2009; 19 Clement, Peeters, Ronckers (bib16) 2015; 41 30709553 - Eur J Surg Oncol. 2019 Sep;45(9):1750-1751 30224249 - Eur J Surg Oncol. 2019 Apr;45(4):713-714 30243466 - Eur J Surg Oncol. 2019 Apr;45(4):711-712 Marti (10.1016/j.ejso.2017.04.002_bib20) 2015; 25 Schlumberger (10.1016/j.ejso.2017.04.002_bib25) 2012; 366 Hughes (10.1016/j.ejso.2017.04.002_bib53) 2010; 148 Avram (10.1016/j.ejso.2017.04.002_bib7) 2013; 98 Tufano (10.1016/j.ejso.2017.04.002_bib10) 2015; 25 Baek (10.1016/j.ejso.2017.04.002_bib32) 2010; 20 Iyer (10.1016/j.ejso.2017.04.002_bib19) 2011; 117 Mallick (10.1016/j.ejso.2017.04.002_bib24) 2012; 366 Randolph (10.1016/j.ejso.2017.04.002_bib29) 2012; 22 Radowsky (10.1016/j.ejso.2017.04.002_bib31) 2014; 24 Phan (10.1016/j.ejso.2017.04.002_bib38) 2008; 158 Tuttle (10.1016/j.ejso.2017.04.002_bib23) 2013; 49 Matsuzu (10.1016/j.ejso.2017.04.002_bib45) 2014; 38 Haymart (10.1016/j.ejso.2017.04.002_bib51) 2013; 98 Brassard (10.1016/j.ejso.2017.04.002_bib35) 2011; 96 Beierwaltes (10.1016/j.ejso.2017.04.002_bib1) 1979; 9 Farahati (10.1016/j.ejso.2017.04.002_bib5) 2000; 88 Zarebczan (10.1016/j.ejso.2017.04.002_bib52) 2010; 148 American Joint Commission on Cancer (10.1016/j.ejso.2017.04.002_bib55) 2017 Hay (10.1016/j.ejso.2017.04.002_bib22) 2007; 13 Webb (10.1016/j.ejso.2017.04.002_bib33) 2012; 97 Van Nostrand (10.1016/j.ejso.2017.04.002_bib8) 2009; 19 Camargo (10.1016/j.ejso.2017.04.002_bib28) 2009; 53 Ilgan (10.1016/j.ejso.2017.04.002_bib14) 2004; 31 Takamura (10.1016/j.ejso.2017.04.002_bib6) 2016; 4 Mazzaferri (10.1016/j.ejso.2017.04.002_bib21) 2007; 13 Haymart (10.1016/j.ejso.2017.04.002_bib50) 2013; 258 Maenpaa (10.1016/j.ejso.2017.04.002_bib3) 2008; 3 Alexander (10.1016/j.ejso.2017.04.002_bib17) 1998; 39 Pacini (10.1016/j.ejso.2017.04.002_bib27) 2006; 154 Nascimento (10.1016/j.ejso.2017.04.002_bib37) 2011; 18 Schuessler (10.1016/j.ejso.2017.04.002_bib48) 2013; 20 Nixon (10.1016/j.ejso.2017.04.002_bib44) 2012; 151 Pilli (10.1016/j.ejso.2017.04.002_bib4) 2007; 92 Haigh (10.1016/j.ejso.2017.04.002_bib46) 2005; 12 Haugen (10.1016/j.ejso.2017.04.002_bib9) 2016; 26 Haymart (10.1016/j.ejso.2017.04.002_bib49) 2013; 98 Sawin (10.1016/j.ejso.2017.04.002_bib2) 1997; 7 Jonklaas (10.1016/j.ejso.2017.04.002_bib11) 2006; 16 Haugen (10.1016/j.ejso.2017.04.002_bib26) 2017; 123 Adam (10.1016/j.ejso.2017.04.002_bib43) 2014; 260 Sacks (10.1016/j.ejso.2017.04.002_bib12) 2010; 20 Rubino (10.1016/j.ejso.2017.04.002_bib18) 2003; 89 Hod (10.1016/j.ejso.2017.04.002_bib13) 2005; 30 Malandrino (10.1016/j.ejso.2017.04.002_bib34) 2011; 96 Amin (10.1016/j.ejso.2017.04.002_bib15) 2017; 67 Bilimoria (10.1016/j.ejso.2017.04.002_bib42) 2007; 246 Clement (10.1016/j.ejso.2017.04.002_bib16) 2015; 41 Bonnet (10.1016/j.ejso.2017.04.002_bib54) 2009; 94 Durante (10.1016/j.ejso.2017.04.002_bib39) 2011; 96 Vaisman (10.1016/j.ejso.2017.04.002_bib40) 2011; 75 Durante (10.1016/j.ejso.2017.04.002_bib41) 2013; 98 Nixon (10.1016/j.ejso.2017.04.002_bib30) 2011; 150 Spencer (10.1016/j.ejso.2017.04.002_bib36) 1999; 9 Haymart (10.1016/j.ejso.2017.04.002_bib47) 2013; 119 |
| References_xml | – volume: 26 start-page: 1 year: 2016 end-page: 133 ident: bib9 article-title: 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Bible – volume: 97 start-page: 2754 year: 2012 end-page: 2763 ident: bib33 article-title: The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients publication-title: J Clin Endocrinol Metab contributor: fullname: Stojadinovic – volume: 39 start-page: 1551 year: 1998 end-page: 1554 ident: bib17 article-title: Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma publication-title: J Nucl Med Off Publ Soc Nucl Med contributor: fullname: Kirsch – volume: 3 start-page: e1885 year: 2008 ident: bib3 article-title: Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study publication-title: PLoS One contributor: fullname: Joensuu – volume: 41 start-page: 925 year: 2015 end-page: 934 ident: bib16 article-title: Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–a systematic review publication-title: Cancer Treat Rev contributor: fullname: Ronckers – volume: 24 start-page: 241 year: 2014 end-page: 244 ident: bib31 article-title: Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Stojadinovic – volume: 92 start-page: 3542 year: 2007 end-page: 3546 ident: bib4 article-title: A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer publication-title: J Clin Endocrinol Metab contributor: fullname: Capoccetti – volume: 38 start-page: 68 year: 2014 end-page: 79 ident: bib45 article-title: Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases publication-title: World J Surg contributor: fullname: Masudo – volume: 96 start-page: 1703 year: 2011 end-page: 1709 ident: bib34 article-title: Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin publication-title: J Clin Endocrinol Metab contributor: fullname: Marescalco – volume: 158 start-page: 77 year: 2008 end-page: 83 ident: bib38 article-title: The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation publication-title: Eur J Endocrinol contributor: fullname: van der Wal – volume: 7 start-page: 163 year: 1997 end-page: 176 ident: bib2 article-title: Radioiodine and the treatment of hyperthyroidism: the early history publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Becker – volume: 30 start-page: 387 year: 2005 end-page: 390 ident: bib13 article-title: Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment publication-title: Clin Nucl Med contributor: fullname: Horne – volume: 49 start-page: 676 year: 2013 end-page: 683 ident: bib23 article-title: Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making publication-title: Oral Oncol contributor: fullname: Sabra – volume: 89 start-page: 1638 year: 2003 end-page: 1644 ident: bib18 article-title: Second primary malignancies in thyroid cancer patients publication-title: Br J Cancer contributor: fullname: Dottorini – volume: 13 start-page: 521 year: 2007 end-page: 533 ident: bib22 article-title: Management of patients with low-risk papillary thyroid carcinoma publication-title: Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol contributor: fullname: Hay – volume: 13 start-page: 498 year: 2007 end-page: 512 ident: bib21 article-title: Management of low-risk differentiated thyroid cancer publication-title: Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol contributor: fullname: Mazzaferri – volume: 96 start-page: 1352 year: 2011 end-page: 1359 ident: bib35 article-title: Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients publication-title: J Clin Endocrinol Metab contributor: fullname: Edet-Sanson – volume: 53 start-page: 1167 year: 2009 end-page: 1175 ident: bib28 article-title: Latin American thyroid society recommendations for the management of thyroid nodules publication-title: Arq Bras Endocrinol Metabol contributor: fullname: Friguglietti – volume: 94 start-page: 1162 year: 2009 end-page: 1167 ident: bib54 article-title: Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment publication-title: J Clin Endocrinol Metab contributor: fullname: Leboulleux – volume: 25 start-page: 15 year: 2015 end-page: 27 ident: bib10 article-title: Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Heller – volume: 366 start-page: 1663 year: 2012 end-page: 1673 ident: bib25 article-title: Strategies of radioiodine ablation in patients with low-risk thyroid cancer publication-title: N Engl J Med contributor: fullname: Borget – volume: 98 start-page: 2001 year: 2013 end-page: 2008 ident: bib49 article-title: Variation in the management of thyroid cancer publication-title: J Clin Endocrinol Metab contributor: fullname: Yang – volume: 123 start-page: 372 year: 2017 Feb 1 end-page: 381 ident: bib26 article-title: 2015 American Thyroid Association mManagement Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? publication-title: Cancer contributor: fullname: Haugen – volume: 9 start-page: 435 year: 1999 end-page: 441 ident: bib36 article-title: Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Nicoloff – volume: 98 start-page: 678 year: 2013 end-page: 686 ident: bib51 article-title: Disease severity and radioactive iodine use for thyroid cancer publication-title: J Clin Endocrinol Metab contributor: fullname: Banerjee – volume: 98 start-page: 1163 year: 2013 end-page: 1171 ident: bib7 article-title: Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging? publication-title: J Clin Endocrinol Metab contributor: fullname: Wong – volume: 246 start-page: 375 year: 2007 end-page: 381 ident: bib42 article-title: Extent of surgery affects survival for papillary thyroid cancer publication-title: Ann Surg contributor: fullname: Ko – volume: 16 start-page: 1229 year: 2006 end-page: 1242 ident: bib11 article-title: Outcomes of patients with differentiated thyroid carcinoma following initial therapy publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Litofsky – volume: 117 start-page: 4439 year: 2011 end-page: 4446 ident: bib19 article-title: Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy publication-title: Cancer contributor: fullname: Ganly – volume: 75 start-page: 112 year: 2011 end-page: 119 ident: bib40 article-title: Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer publication-title: Clin Endocrinol contributor: fullname: Michael Tuttle – volume: 150 start-page: 1242 year: 2011 end-page: 1249 ident: bib30 article-title: The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer publication-title: Surgery contributor: fullname: Patel – volume: 20 start-page: 147 year: 2010 end-page: 152 ident: bib32 article-title: Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Kang – volume: 258 start-page: 354 year: 2013 end-page: 358 ident: bib50 article-title: The relationship between extent of thyroid cancer surgery and use of radioactive iodine publication-title: Ann Surg contributor: fullname: Yang – volume: 119 start-page: 259 year: 2013 end-page: 265 ident: bib47 article-title: The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer publication-title: Cancer contributor: fullname: Griggs – year: 2017 ident: bib55 article-title: Cancer staging manual contributor: fullname: American Joint Commission on Cancer – volume: 31 start-page: 825 year: 2004 end-page: 830 ident: bib14 article-title: Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma publication-title: Eur J Nucl Med Mol Imaging contributor: fullname: Pabuscu – volume: 148 start-page: 1100 year: 2010 end-page: 1106 ident: bib53 article-title: Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer publication-title: Surgery contributor: fullname: Doherty – volume: 88 start-page: 1470 year: 2000 end-page: 1476 ident: bib5 article-title: Inverse association between age at the time of radiation exposure and extent of disease in cases of radiation-induced childhood thyroid carcinoma in Belarus publication-title: Cancer contributor: fullname: Reiners – volume: 67 start-page: 93 year: 2017 end-page: 99 ident: bib15 article-title: The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging publication-title: CA Cancer J Clin contributor: fullname: Edge – volume: 4 start-page: 647 year: 2016 ident: bib6 article-title: Radiation and risk of thyroid cancer: Fukushima and Chernobyl publication-title: Lancet Diabetes Endocrinol contributor: fullname: Demidchik – volume: 22 start-page: 1144 year: 2012 end-page: 1152 ident: bib29 article-title: The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Heller – volume: 18 start-page: R29 year: 2011 end-page: R40 ident: bib37 article-title: Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level publication-title: Endocrine-related Cancer contributor: fullname: Al Ghuzlan – volume: 260 start-page: 601 year: 2014 end-page: 605 ident: bib43 article-title: Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients publication-title: Ann Surg contributor: fullname: Gu – volume: 9 start-page: 151 year: 1979 end-page: 155 ident: bib1 article-title: The history of the use of radioactive iodine publication-title: Semin Nucl Med contributor: fullname: Beierwaltes – volume: 96 start-page: 3059 year: 2011 end-page: 3061 ident: bib39 article-title: Management of papillary thyroid cancer patients in absence of postoperative radioiodine remnant ablation: tailoring follow-up by neck sonography publication-title: J Clin Endocrinol Metab contributor: fullname: Filetti – volume: 151 start-page: 571 year: 2012 end-page: 579 ident: bib44 article-title: Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy publication-title: Surgery contributor: fullname: Patel – volume: 20 start-page: 733 year: 2013 end-page: 738 ident: bib48 article-title: Surgeon training and use of radioactive iodine in stage I thyroid cancer patients publication-title: Ann Surg Oncol contributor: fullname: Haymart – volume: 148 start-page: 1075 year: 2010 end-page: 1080 ident: bib52 article-title: Training our future endocrine surgeons: a look at the endocrine surgery operative experience of U.S. surgical residents publication-title: Surgery contributor: fullname: Sippel – volume: 98 start-page: 636 year: 2013 end-page: 642 ident: bib41 article-title: Papillary thyroid cancer: time course of recurrences during postsurgery surveillance publication-title: J Clin Endocrinol Metab contributor: fullname: Torlontano – volume: 25 start-page: 865 year: 2015 end-page: 866 ident: bib20 article-title: Inappropriate use of radioactive iodine for low-risk papillary thyroid cancer is most common in regions with poor access to healthcare publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Morris – volume: 154 start-page: 787 year: 2006 end-page: 803 ident: bib27 article-title: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium publication-title: Eur J Endocrinol contributor: fullname: Dralle – volume: 19 start-page: 849 year: 2009 end-page: 855 ident: bib8 article-title: The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer publication-title: Thyroid Off J Am Thyroid Assoc contributor: fullname: Atkins – volume: 366 start-page: 1674 year: 2012 end-page: 1685 ident: bib24 article-title: Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer publication-title: N Engl J Med contributor: fullname: Yap – volume: 20 start-page: 1235 year: 2010 end-page: 1245 ident: bib12 article-title: The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008 publication-title: Thyroid: Off J Am Thyroid Assoc contributor: fullname: Braunstein – volume: 12 start-page: 81 year: 2005 end-page: 89 ident: bib46 article-title: Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer publication-title: Ann Surg Oncol contributor: fullname: Rotstein – volume: 13 start-page: 521 issue: 5 year: 2007 ident: 10.1016/j.ejso.2017.04.002_bib22 article-title: Management of patients with low-risk papillary thyroid carcinoma publication-title: Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol contributor: fullname: Hay – volume: 18 start-page: R29 issue: 2 year: 2011 ident: 10.1016/j.ejso.2017.04.002_bib37 article-title: Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level publication-title: Endocrine-related Cancer contributor: fullname: Nascimento – volume: 13 start-page: 498 issue: 5 year: 2007 ident: 10.1016/j.ejso.2017.04.002_bib21 article-title: Management of low-risk differentiated thyroid cancer publication-title: Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol contributor: fullname: Mazzaferri – volume: 9 start-page: 435 issue: 5 year: 1999 ident: 10.1016/j.ejso.2017.04.002_bib36 article-title: Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.1999.9.435 contributor: fullname: Spencer – volume: 88 start-page: 1470 issue: 6 year: 2000 ident: 10.1016/j.ejso.2017.04.002_bib5 article-title: Inverse association between age at the time of radiation exposure and extent of disease in cases of radiation-induced childhood thyroid carcinoma in Belarus publication-title: Cancer doi: 10.1002/(SICI)1097-0142(20000315)88:6<1470::AID-CNCR27>3.0.CO;2-W contributor: fullname: Farahati – volume: 53 start-page: 1167 issue: 9 year: 2009 ident: 10.1016/j.ejso.2017.04.002_bib28 article-title: Latin American thyroid society recommendations for the management of thyroid nodules publication-title: Arq Bras Endocrinol Metabol doi: 10.1590/S0004-27302009000900014 contributor: fullname: Camargo – year: 2017 ident: 10.1016/j.ejso.2017.04.002_bib55 article-title: Cancer staging manual contributor: fullname: American Joint Commission on Cancer – volume: 19 start-page: 849 issue: 8 year: 2009 ident: 10.1016/j.ejso.2017.04.002_bib8 article-title: The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.2008.0419 contributor: fullname: Van Nostrand – volume: 22 start-page: 1144 issue: 11 year: 2012 ident: 10.1016/j.ejso.2017.04.002_bib29 article-title: The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.2012.0043 contributor: fullname: Randolph – volume: 24 start-page: 241 issue: 2 year: 2014 ident: 10.1016/j.ejso.2017.04.002_bib31 article-title: Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.2012.0567 contributor: fullname: Radowsky – volume: 25 start-page: 15 issue: 1 year: 2015 ident: 10.1016/j.ejso.2017.04.002_bib10 article-title: Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.2014.0098 contributor: fullname: Tufano – volume: 96 start-page: 1703 issue: 6 year: 2011 ident: 10.1016/j.ejso.2017.04.002_bib34 article-title: Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-2695 contributor: fullname: Malandrino – volume: 75 start-page: 112 issue: 1 year: 2011 ident: 10.1016/j.ejso.2017.04.002_bib40 article-title: Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2011.04002.x contributor: fullname: Vaisman – volume: 25 start-page: 865 issue: 7 year: 2015 ident: 10.1016/j.ejso.2017.04.002_bib20 article-title: Inappropriate use of radioactive iodine for low-risk papillary thyroid cancer is most common in regions with poor access to healthcare publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.2015.0112 contributor: fullname: Marti – volume: 258 start-page: 354 issue: 2 year: 2013 ident: 10.1016/j.ejso.2017.04.002_bib50 article-title: The relationship between extent of thyroid cancer surgery and use of radioactive iodine publication-title: Ann Surg doi: 10.1097/SLA.0b013e31826c8915 contributor: fullname: Haymart – volume: 3 start-page: e1885 issue: 4 year: 2008 ident: 10.1016/j.ejso.2017.04.002_bib3 article-title: Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study publication-title: PLoS One doi: 10.1371/journal.pone.0001885 contributor: fullname: Maenpaa – volume: 20 start-page: 147 issue: 2 year: 2010 ident: 10.1016/j.ejso.2017.04.002_bib32 article-title: Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.2008.0243 contributor: fullname: Baek – volume: 151 start-page: 571 issue: 4 year: 2012 ident: 10.1016/j.ejso.2017.04.002_bib44 article-title: Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy publication-title: Surgery doi: 10.1016/j.surg.2011.08.016 contributor: fullname: Nixon – volume: 4 start-page: 647 issue: 8 year: 2016 ident: 10.1016/j.ejso.2017.04.002_bib6 article-title: Radiation and risk of thyroid cancer: Fukushima and Chernobyl publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(16)30112-7 contributor: fullname: Takamura – volume: 89 start-page: 1638 issue: 9 year: 2003 ident: 10.1016/j.ejso.2017.04.002_bib18 article-title: Second primary malignancies in thyroid cancer patients publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601319 contributor: fullname: Rubino – volume: 92 start-page: 3542 issue: 9 year: 2007 ident: 10.1016/j.ejso.2017.04.002_bib4 article-title: A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0225 contributor: fullname: Pilli – volume: 98 start-page: 1163 issue: 3 year: 2013 ident: 10.1016/j.ejso.2017.04.002_bib7 article-title: Preablation 131-I scans with SPECT/CT in postoperative thyroid cancer patients: what is the impact on staging? publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-3630 contributor: fullname: Avram – volume: 158 start-page: 77 issue: 1 year: 2008 ident: 10.1016/j.ejso.2017.04.002_bib38 article-title: The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation publication-title: Eur J Endocrinol doi: 10.1530/EJE-07-0399 contributor: fullname: Phan – volume: 97 start-page: 2754 issue: 8 year: 2012 ident: 10.1016/j.ejso.2017.04.002_bib33 article-title: The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-1533 contributor: fullname: Webb – volume: 98 start-page: 678 issue: 2 year: 2013 ident: 10.1016/j.ejso.2017.04.002_bib51 article-title: Disease severity and radioactive iodine use for thyroid cancer publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-3160 contributor: fullname: Haymart – volume: 20 start-page: 1235 issue: 11 year: 2010 ident: 10.1016/j.ejso.2017.04.002_bib12 article-title: The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008 publication-title: Thyroid: Off J Am Thyroid Assoc doi: 10.1089/thy.2009.0455 contributor: fullname: Sacks – volume: 38 start-page: 68 issue: 1 year: 2014 ident: 10.1016/j.ejso.2017.04.002_bib45 article-title: Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases publication-title: World J Surg doi: 10.1007/s00268-013-2224-1 contributor: fullname: Matsuzu – volume: 366 start-page: 1663 issue: 18 year: 2012 ident: 10.1016/j.ejso.2017.04.002_bib25 article-title: Strategies of radioiodine ablation in patients with low-risk thyroid cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1108586 contributor: fullname: Schlumberger – volume: 16 start-page: 1229 issue: 12 year: 2006 ident: 10.1016/j.ejso.2017.04.002_bib11 article-title: Outcomes of patients with differentiated thyroid carcinoma following initial therapy publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.2006.16.1229 contributor: fullname: Jonklaas – volume: 12 start-page: 81 issue: 1 year: 2005 ident: 10.1016/j.ejso.2017.04.002_bib46 article-title: Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer publication-title: Ann Surg Oncol doi: 10.1007/s10434-004-1165-1 contributor: fullname: Haigh – volume: 246 start-page: 375 issue: 3 year: 2007 ident: 10.1016/j.ejso.2017.04.002_bib42 article-title: Extent of surgery affects survival for papillary thyroid cancer publication-title: Ann Surg doi: 10.1097/SLA.0b013e31814697d9 contributor: fullname: Bilimoria – volume: 366 start-page: 1674 issue: 18 year: 2012 ident: 10.1016/j.ejso.2017.04.002_bib24 article-title: Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1109589 contributor: fullname: Mallick – volume: 9 start-page: 151 issue: 3 year: 1979 ident: 10.1016/j.ejso.2017.04.002_bib1 article-title: The history of the use of radioactive iodine publication-title: Semin Nucl Med doi: 10.1016/S0001-2998(79)80023-9 contributor: fullname: Beierwaltes – volume: 154 start-page: 787 issue: 6 year: 2006 ident: 10.1016/j.ejso.2017.04.002_bib27 article-title: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium publication-title: Eur J Endocrinol doi: 10.1530/eje.1.02158 contributor: fullname: Pacini – volume: 119 start-page: 259 issue: 2 year: 2013 ident: 10.1016/j.ejso.2017.04.002_bib47 article-title: The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer publication-title: Cancer doi: 10.1002/cncr.27721 contributor: fullname: Haymart – volume: 26 start-page: 1 issue: 1 year: 2016 ident: 10.1016/j.ejso.2017.04.002_bib9 article-title: 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.2015.0020 contributor: fullname: Haugen – volume: 96 start-page: 1352 issue: 5 year: 2011 ident: 10.1016/j.ejso.2017.04.002_bib35 article-title: Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-2708 contributor: fullname: Brassard – volume: 39 start-page: 1551 issue: 9 year: 1998 ident: 10.1016/j.ejso.2017.04.002_bib17 article-title: Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma publication-title: J Nucl Med Off Publ Soc Nucl Med contributor: fullname: Alexander – volume: 94 start-page: 1162 issue: 4 year: 2009 ident: 10.1016/j.ejso.2017.04.002_bib54 article-title: Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-1931 contributor: fullname: Bonnet – volume: 117 start-page: 4439 issue: 19 year: 2011 ident: 10.1016/j.ejso.2017.04.002_bib19 article-title: Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy publication-title: Cancer doi: 10.1002/cncr.26070 contributor: fullname: Iyer – volume: 67 start-page: 93 issue: 2 year: 2017 ident: 10.1016/j.ejso.2017.04.002_bib15 article-title: The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging publication-title: CA Cancer J Clin doi: 10.3322/caac.21388 contributor: fullname: Amin – volume: 150 start-page: 1242 issue: 6 year: 2011 ident: 10.1016/j.ejso.2017.04.002_bib30 article-title: The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer publication-title: Surgery doi: 10.1016/j.surg.2011.09.007 contributor: fullname: Nixon – volume: 31 start-page: 825 issue: 6 year: 2004 ident: 10.1016/j.ejso.2017.04.002_bib14 article-title: Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-004-1460-x contributor: fullname: Ilgan – volume: 41 start-page: 925 issue: 10 year: 2015 ident: 10.1016/j.ejso.2017.04.002_bib16 article-title: Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–a systematic review publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2015.09.001 contributor: fullname: Clement – volume: 49 start-page: 676 issue: 7 year: 2013 ident: 10.1016/j.ejso.2017.04.002_bib23 article-title: Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: a practical approach to clinical decision making publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2013.03.444 contributor: fullname: Tuttle – volume: 7 start-page: 163 issue: 2 year: 1997 ident: 10.1016/j.ejso.2017.04.002_bib2 article-title: Radioiodine and the treatment of hyperthyroidism: the early history publication-title: Thyroid Off J Am Thyroid Assoc doi: 10.1089/thy.1997.7.163 contributor: fullname: Sawin – volume: 96 start-page: 3059 issue: 10 year: 2011 ident: 10.1016/j.ejso.2017.04.002_bib39 article-title: Management of papillary thyroid cancer patients in absence of postoperative radioiodine remnant ablation: tailoring follow-up by neck sonography publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-1379 contributor: fullname: Durante – volume: 30 start-page: 387 issue: 6 year: 2005 ident: 10.1016/j.ejso.2017.04.002_bib13 article-title: Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment publication-title: Clin Nucl Med doi: 10.1097/01.rlu.0000162602.48653.54 contributor: fullname: Hod – volume: 98 start-page: 2001 issue: 5 year: 2013 ident: 10.1016/j.ejso.2017.04.002_bib49 article-title: Variation in the management of thyroid cancer publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-3355 contributor: fullname: Haymart – volume: 148 start-page: 1100 issue: 6 year: 2010 ident: 10.1016/j.ejso.2017.04.002_bib53 article-title: Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer publication-title: Surgery doi: 10.1016/j.surg.2010.09.019 contributor: fullname: Hughes – volume: 98 start-page: 636 issue: 2 year: 2013 ident: 10.1016/j.ejso.2017.04.002_bib41 article-title: Papillary thyroid cancer: time course of recurrences during postsurgery surveillance publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-3401 contributor: fullname: Durante – volume: 20 start-page: 733 issue: 3 year: 2013 ident: 10.1016/j.ejso.2017.04.002_bib48 article-title: Surgeon training and use of radioactive iodine in stage I thyroid cancer patients publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2745-0 contributor: fullname: Schuessler – volume: 123 start-page: 372 issue: 3 year: 2017 ident: 10.1016/j.ejso.2017.04.002_bib26 article-title: 2015 American Thyroid Association mManagement Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? publication-title: Cancer doi: 10.1002/cncr.30360 contributor: fullname: Haugen – volume: 260 start-page: 601 issue: 4 year: 2014 ident: 10.1016/j.ejso.2017.04.002_bib43 article-title: Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients publication-title: Ann Surg doi: 10.1097/SLA.0000000000000925 contributor: fullname: Adam – volume: 148 start-page: 1075 issue: 6 year: 2010 ident: 10.1016/j.ejso.2017.04.002_bib52 article-title: Training our future endocrine surgeons: a look at the endocrine surgery operative experience of U.S. surgical residents publication-title: Surgery doi: 10.1016/j.surg.2010.09.032 contributor: fullname: Zarebczan |
| SSID | ssj0009379 |
| Score | 2.3937745 |
| SecondaryResourceType | review_article |
| Snippet | Abstract A remarkable, evidence-based trend toward de-escalation has reformed the practice of radioactive iodine (RAI) administration for thyroid cancer... A remarkable, evidence-based trend toward de-escalation has reformed the practice of radioactive iodine (RAI) administration for thyroid cancer patients.... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 348 |
| SubjectTerms | ATA Guidelines Biomarkers, Tumor - analysis Combined Modality Therapy De-escalation Decision Making Hematology, Oncology and Palliative Medicine Humans Iodine Radioisotopes - therapeutic use Patient Selection Practice Guidelines as Topic Radioactive iodine Radiotherapy Dosage Risk Assessment Risk Factors Surgery Thyroid cancer Thyroid Neoplasms - radiotherapy Thyroid Neoplasms - surgery Thyroidectomy Thyroidectomy - methods |
| Title | Selective use of radioactive iodine (RAI) in thyroid cancer: no longer “one size fits all” |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0748798317304444 https://dx.doi.org/10.1016/j.ejso.2017.04.002 https://www.ncbi.nlm.nih.gov/pubmed/28545679 https://search.proquest.com/docview/1903170543 |
| Volume | 44 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SDZReSt_dJF1U6KGluGtbT_e2LA2bPpaSNJBThSzL4LCsw3r3kkPID2n-XH5JR7acUvo49GghMfbMaL6xNA-Al4gxrjCpjWxqeMQYFVEuWRwx__PhKOOybANk52J2wj6c8tMtmPa5MD6sMtj-zqa31jqMjAM3x-dVNT5G8FMyUwiA1Bc9Y9uwg3CUqgHsTA4_zuY_a--Gkns4P_ILQu5MF-blzhqfA5jItuJpOF35Az79zf9scejgPtwLDiSZdO_4ALbc8iHc-RyuyB_Bt-O2sw0aMbJpHKlLsjJFVZtuqKoRqxx5dTQ5fE2qJUExreqqINYLf_WOzGuyqP1BH7m5-l7jzKa6cKSs1g0xi8XN1fVjODl4_3U6i0IThciyJFlHMmXWlJIK36OK54bm6BJmKIPYMpsWWckEyzPla0ZyrgrH0pgqW5hS2FQlhtInMFgivWdAhC_u5XyXGpWjUEVmuFC0YEXiHKM2HsKbnnX6vKuVofsgsjPtGa09o3XMNDJ6CLLnru6zQNFuuSZsokYnukl1rH8T9BD47cpfdEUjDPyT4oteiBo3kb8ZMUtXb5BShrZNovdKh_C0k-7tF_gUUy5ktvufVPfgLj6pLm5tHwbr1cY9R0dmnY9g--1lMkJ1nR59-jIKavsDPC3wzw |
| link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkNpeEH0vpcWVemhVRZvEz3BboaLdAnsoIHGq5TiOFLTaoM3upSd-SPvn-CUdJw6oKvTA1bE1yYznEXvmG4CP6GNcYVIb2dTwiDEqolyyOGL-58NRxmXZJshOxfiMfTvn52uw39fC-LTKYPs7m95a6zAyDNwcXlbV8ASdn5KZQgdIPegZewQbGA1kqJ0bo8nheHqLvRsg93B-5BeE2pkuzctdNL4GMJEt4mk4XbnDP90Xf7Z-6GALNkMASUbdOz6DNTd_Do-PwxX5C_hx0na2QSNGVo0jdUkWpqhq0w1VNfoqRz59H00-k2pOUEyLuiqI9cJf7JFpTWa1P-gj11e_apzZVD8dKatlQ8xsdn31-yWcHXw93R9HoYlCZFmSLCOZMmtKSYXvUcVzQ3MMCTOUQWyZTYusZILlmfKYkZyrwrE0psoWphQ2VYmh9BWsz5HeGyDCg3s536VG5ShUkRkuFC1YkTjHqI0H8KVnnb7ssDJ0n0R2oT2jtWe0jplGRg9A9tzVfRUo2i3XBCVqdKKbVMf6H0EPgN-s_GuvaHQD_6X4oReiRiXyNyNm7uoVUsrQtkmMXukAXnfSvfkCX2LKhcy2H0h1F56MT4-P9NFkevgWnuIT1eWw7cD6crFy7zCoWebvw6b9A4cR8S4 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selective+use+of+radioactive+iodine+%28RAI%29+in+thyroid+cancer%3A+No+longer+%E2%80%9Cone+size+fits+all%E2%80%9D&rft.jtitle=European+journal+of+surgical+oncology&rft.au=Marti%2C+J.L.&rft.au=Morris%2C+L.G.T.&rft.au=Ho%2C+A.S.&rft.date=2018-03-01&rft.pub=Elsevier+Ltd&rft.issn=0748-7983&rft.eissn=1532-2157&rft.volume=44&rft.issue=3&rft.spage=348&rft.epage=356&rft_id=info:doi/10.1016%2Fj.ejso.2017.04.002&rft.externalDocID=S0748798317304444 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0748-7983&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0748-7983&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0748-7983&client=summon |